Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors
Clinical trial NCT07560943 · RECRUITING
Trial details
- NCT number
- NCT07560943
- Sponsor
- West China Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-28
- Primary completion
- 2027-04-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.